( MENAFN - GlobeNewsWire - Nasdaq) The Global Thiamine market Size was Valued At USD 1.3 Billion in 2023 and the Worldwide Thiamine Market Size is Expected to Reach USD 2.2 Billion By 2033, according to a research report published by Spherical Insights & Consulting.
Companies covered: DSM, Chemizo Enterprise, Xinfa Pharmaceutical Co., Ltd., Jiangxi Tianxin Pharmaceutical Co.
, Ltd., Nutricost, McCartan's Pharmacy, Jiangsu Jubang Pharmaceutical Co., Ltd.
, HPC, and Others Key Vendors. New York, United States , May 31, 2024 (GLOBE NEWSWIRE) -- The Global Thiamine Market Size to Grow from USD 1.3 Billion in 2023 to USD 2.
2 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period. Get a Sample PDF Brochure: Thiamine, often known as vitamin B1, is an essential nutrient that aids in energy metabolism and nervous system function.
Thiamine is widely used in dietary supplements, food and beverages, pharmaceuticals, and animal feed, resulting in high global demand. The increased consumer knowledge of the benefits of vitamins and a healthy diet drives up demand for thiamine supplements and fortified foods. There is a rising emphasis on preventative healthcare and the benefits of thiamine in the treatment of beriberi, Wernicke-Korsakoff syndrome, and other neurological disorders.
Thiamine is used in the creation of a wide range of pharmaceutical products, including multivitamin pills, injectable vitamins, and therapeutic formulations for specific health .
